Impact of Acute Rejection on Kidney Allograft Outcomes in Recipients on Rapid Steroid Withdrawal
Author Information
Author(s): R. L. Heilman, S. Nijim, H. A. Chakkera, Y. Devarapalli, A. A. Moss, D. C. Mulligan, M. J. Mazur, K. Hamawi, J. W. Williams, K. S. Reddy
Primary Institution: Mayo Clinic
Hypothesis
The study aims to investigate the impact of clinical acute rejection and subclinical rejection on outcomes in kidney transplant recipients treated with rapid steroid withdrawal.
Conclusion
Both subclinical and clinical acute rejection are associated with inferior graft survival in kidney transplant recipients on rapid steroid withdrawal.
Supporting Evidence
- 10% of patients experienced subclinical rejection, while 7.8% had clinical rejection.
- The estimated 5-year death-censored graft survival was 81% in subclinical rejection and 78% in clinical rejection.
- Significant differences in graft survival were observed between rejection groups and the control group.
Takeaway
This study found that when kidney transplant patients stop taking steroids quickly, those who experience rejection of the kidney have a harder time keeping their transplant healthy.
Methodology
This retrospective study included all adult kidney transplant recipients treated with rapid steroid withdrawal from July 2003 to June 2008, analyzing death-censored graft survival as the primary outcome.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the exclusion of certain patient groups.
Limitations
The study is retrospective and may not account for all variables influencing graft survival.
Participant Demographics
The study included adult kidney transplant recipients, with a mean age of approximately 53 years.
Statistical Information
P-Value
P < .0001
Confidence Interval
95% CI 3.39–24.2 for CR vs control; 95% CI 1.30–13.7 for SR vs control
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website